Eisai
4523.T
#2025
Rank
NZ$13.82 B
Marketcap
$49.05
Share price
-0.60%
Change (1 day)
-39.15%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.89. In 2022 the company made an earnings per share (EPS) of $2.85 a decrease over its 2021 EPS that were of $12.67.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5424.04%
2022$2.85-77.48%
2021$12.67-41.88%
2020$21.80-0.94%
2019$22.0152.59%
2018$14.42124.17%
2017$6.43-49.42%
2016$12.7237.08%
2015$9.28-11.75%
2014$10.52-3.23%
2013$10.87-18.56%
2012$13.34-15.51%
2011$15.79-3.75%
2010$16.41-1.36%
2009$16.64